Harmony Biosciences Holdings Overview
Harmony Biosciences Holdings Target Price
Analysts' 12-month price predictions for HRMY.
Share Price
$34.37
Average Target Price
$48.00
39.7% upside
39.7% upside1 analysts in the last 4 months
High: $48 | Low: $48
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-04-28 | UBS | $48 | 39.7% upside |  |
| 2024-10-30 | Goldman SachsCorinne Jenkins | $28 |  18.5% downside | |
| 2024-10-10 | Mizuho SecuritiesGraig Suvannavejh | $52 | 51.3% upside | |
| 2024-09-10 | UBSAshwani Verma | $56 | 62.9% upside | |
| 2024-08-08 | Mizuho SecuritiesGraig Suvannavejh | $42 | 22.2% upside | |
| 2024-06-24 | OppenheimerFrancois Brisebois | $56 | 62.9% upside | |
| 2024-05-01 | NeedhamAmi Fadia | $52 | 51.3% upside | |
| 2024-04-30 | Raymond JamesDanielle Brill | $37 | 7.7% upside | |
| 2022-10-14 | JefferiesChris Howerton | $61 | 77.5% upside | |